Summary
The question of the existence of postjunctional, contraction-mediating α2-adrenoceptors, in addition to the known α1-adrenoceptors, was studied in the mouse isolated vas deferens. Both the α1-selective agonist phenylephrine and the α2-selective agonist 5-bromo-6-(2imidazolin-2-ylamino)-quinoxaline (UK 14,304) caused contraction of the vas deferens. In the presence of the α1-selective antagonist prazosin (added in order to prevent an α1 component in the effect of high concentrations of UK 14,304), the α2-selective antagonists yohimbine and idazoxan shifted the concentration—response curve of UK 14,304 to the right in a manner compatible with competitive antagonism and with dissociation constants KB indicating the involvement of α2-adrenoceptors. The maximal contraction elicited by UK 14,304 (in the presence of prazosin) was much lower than the maximal contraction elicited by phenylephrine. The effect of UK 14,304 was not changed by the P2-purinoceptor agonist α,β-methylene-ATP and was reduced by neuropeptideY, but was markedly enhanced by relatively low concentrations of phenylephrine. When the sympathetic fibres of the vas deferens were stimulated by trains of ten widely spaced (0.5 Hz) electric pulses, the tissue responded with ten separate twitches in which purinergic and adrenergic components were isolated by prazosin and suramin, respectively. Prazosin reduced the first adrenergic twitch in these trains at concentrations close to its KB value at α1-adrenoceptors, whereas yohimbine and idazoxan reduced the first adrenergic twitch at concentrations far lower than their KB values at α1-adrenoceptors. The results indicate that the smooth muscle of the mouse vas deferens possesses contraction-mediating α2-adrenoceptors. They are activated by UK 14,304 and probably also by noradrenaline of neural origin. Responses mediated by the α2-adrenoceptors are enhanced by simultaneous α1-receptor activation, an interaction that may increase the contribution of the α2-adrenoceptors to the adrenergic phase of neurogenic contractions.
Similar content being viewed by others
References
Alabaster VA, Keir RF, Peters CJ (1985) Comparison of activity of alpha-adrenoceptor agonists and antagonists in dog and rabbit saphenous vein. Naunyn-Schmiedeberg's Arch Pharmacol 330:33–36
Amobi NIB, Smith ICH (1984) Changes in the phases of the twitch responses of the rat vas deferens to low-frequency stimulation. J Physiol (Lond) 357:106P
Amobi NIB, Smith ICH (1987) Adrenergic and “non-adrenergic” contributions to the two-component tetanus in the rat vas deferens. Eur J Pharmacol 135:173–182
Angus JA, Cocks TM, Satoh K (1986) α2-Adrenoceptors and endothelium-dependent relaxation in canine large arteries. Br J Pharmacol 88:767–777
Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48–58
Brown DA, Docherty JR, French AM, MacDonald A, McGrath JC, Scott NC (1983) Separation of adrenergic and non-adrenergic contractions to field stimulation in the rat vas deferens. Br J Pharmacol 79:379–393
Bültmann R, von Kügelgen I (1990) Adrenergic and purinergic components of neurogenic contractions of the mouse vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 341:R86
Bylund DB, Ray-Prenger C (1989) Alpha-2A and alpha-2B adrenergic receptor subtypes: attenuation of cyclic AMP production in cell lines containing only one receptor subtype. J Pharmacol Exp Ther 251:640–644
Cambridge D (1981) UK 14,304, a potent and selective α2-agonist for the characterisation of α-adrenoceptor subtypes. Eur J Pharmacol 72:413–415
Daly CJ, McGrath JC, Wilson VG (1988) Pharmacological analysis of postjunctional a-adrenoceptors mediating contractions to (−)-noradrenaline in the rabbit isolated lateral saphenous vein can be explained by interacting responses to simultaneous activation of α1- and a2-adrenoceptors. Br J Pharmacol 95:485–500
Docherty JR (1989) The pharmacology of α1-and α2-adrenoceptors: evidence for and against a further subdivision. Pharmacol Ther 44:241–284
Doxey JC, Lane AC, Roach AG, Virdee NK (1984) Comparison of the α-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine. Naunyn-Schmiedeberg's Arch Pharmacol 325:136–144
Dunn PM, Blakeley AGH (1988) Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens. Br J Pharmacol 93:243–245
Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Catecholamines. Handbook of experimental pharmacology, vol 33. Springer, Berlin Heidelberg New York, pp 283–335
Furma T (1988) Precontraction-induced contractile response of isolated canine portal vein to alpha-2 adrenoceptor agonists. Naunyn-Schmiedeberg's Arch Pharmacol 337:525–530
Goncalves J, Proenca J, Albuquerque AA, Paiva MQ (1989) Hypothermia induces supersensitivity of mouse vas deferens to adrenergic agonists: evidence for postjunctional α2-adrenoceptors. J Pharm Pharmacol 41:52–54
Guimarães S, Paiva MQ, Moura D (1987) Alpha2-adrenoceptor-mediated responses to so-called selective alpha1-adrenoceptor agonists after partial blockade of alpha1-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 335:397–402
Härfstrand A, Fuxe K (1987) Simultaneous central administration of adrenaline and neuropeptide Y leads to antagonistic interactions in vasodepressor responses in awake male rats. Acta Physiol Scand 130:529–531
Illes P, Regenold JT (1990) Interaction between neuropeptide Y and noradrenaline on central catecholamine neurons. Nature 344:62–63
Lai RT, Watanabe Y, Yoshida H (1983) The influence of aging on α-adrenoceptors in rat heart and vas deferens. Jpn J Pharmacol 33:241–245
Limberger N, Starke K (1983) Partial agonist effect of 2-[2-(1,4-benzodioxanyl)]-2-imidazoline (RX 781094) at presynaptic α2-adrenoceptors in rabbit ear artery. Naunyn-Schmiedeberg's Arch Pharmacol 324:75–78
Limberger N, Mayer A, Zier G, Valenta B, Starke K, Singer EA (1989) Estimation of pA2 values at presynaptic α2-autoreceptors in rabbit and rat brain cortex in the absence of autoinhibition. Naunyn-Schmiedeberg's Arch Pharmacol 340:639–647
MacKay D (1978) How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated? J Pharm Pharmacol 30:312–313
Marshall I, Nasmyth PA, Nicholl CG, Shepperson NB (1978) α-Adrenoceptors in the mouse vas deferens and their effects on its response to electrical stimulation. Br J Pharmacol 62:147–151
McGrath JC (1984) α-Adrenoceptor antagonism by apoyohimbine and some observations on the pharmacology of α-adrenoceptors in the rat anococcygeus and vas deferens. Br J Pharmacol 82:769–781
McGrath JC, Brown CM, Wilson VG (1989) Alpha-adrenoceptors: a critical review. Med Res Rev 9:407–533
Nasseri A, Barakeh JF, Abel PW, Minneman KP (1985) Reserpine-induced postjunctional supersensitivity in rat vas deferens and caudal artery without changes in alpha adrenergic receptors. J Pharmacol Exp Ther 234:350–357
Schümann HJ, Lues I (1983) Postjunctional α-adrenoceptors in the isolated saphenous vein of the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 323:328–334
Shepperson NB (1984) α2-Adrenoceptor agonists potentiate responses mediated by α1-adrenoceptors in the cat nictitating membrane. Br J Pharmacol 83:463–469
Starke K, Endo T, Taube HD (1975) Relative pre- and postsynaptic potencies of α-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 291:55–78
Stjärne L, Åstrand P (1985) Relative pre- and postjunctional roles of noradrenaline and adenosine 5′-triphosphate as neurotransmitters of the sympathetic nerves of guinea-pig and mouse vas deferens. Neuroscience 14:929–946
Stjärne L, Lundberg JM, Åstrand P (1986) Neuropeptide Y — a cotransmitter with noradrenaline and adenosine 5′-triphosphate in the sympathetic nerves of the mouse vas deferens? A biochemical, physiological and electropharmacological study. Neuroscience 18:151–166
Vila E, Macrae IM (1990) Effect of neuropeptide Y on α2-adrenoceptor-mediated cardiovascular responses in the pithed rat. Br J Pharmacol 100:840–842
Von Kügelgen I, Bültmann R, Starke K (1989) Effects of suramin and α,β-methylene ATP indicate noradrenaline-ATP co-transmission in the response of the mouse vas deferens to single and low frequency pulses. Naunyn-Schmiedeberg's Arch Pharmacol 340:760–763
Wallenstein S, Zucker CL, Fleiss JL (1980) Some statistical methods useful in circulation research. Circ Res 47:1–9
Watanabe Y, Lai RT, Maeda H, Yoshida H (1982) Reserpine and sympathetic denervation cause an increase of postsynaptic α2-adrenoceptors. Eur J Pharmacol 80:105–108
Watanabe Y, Lai RT, Yoshida H (1983) Increase of [3H]clonidine binding sites induced by adenosine receptor agonists in rat vas deferens in vitro. Eur J Pharmacol 86:265–269
Xiao XH, Rand MJ (1989) α2-Adrenoceptor agonists enhance responses to certain other vasoconstrictor agonists in the rat tail artery. Br J Pharmacol 96:539–546
Author information
Authors and Affiliations
Additional information
Send offprint requests to R. Bültmann at the above address
Rights and permissions
About this article
Cite this article
Bültmann, R., von Kügelgen, I. & Starke, K. Contraction-mediating α2-adrenoceptors in the mouse vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 343, 623–632 (1991). https://doi.org/10.1007/BF00184294
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00184294